Opinions
The Monthly Gems by Allan Tong
Medmira Inc
MIR-X
TOP PICK
May 11, 2020
In Canada, this smallcap (C$210 million) biotech in Halifax submitted its antibody test to the FDA. Since April 22, MedMira has soared from 6 cents/share to over 30. There's scant coverage or even stock metrics to report. Also MedMira is one of many companies to submit such tests to the FDA, but it's worth keeping on your radar. At this stage of pandemic, I wouldn't rule out any stock that could effectively fight the virus.
$0.345
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.